Cargando…
Prognostic impact of lymphadenectomy on outcomes of sublobar resection for non-small cell lung cancer ≤1 or >1 to 2 cm
BACKGROUND: Lymphadenectomy is an important part of surgical treatment for non-small cell lung cancer (NSCLC). However, the prognostic impact of lymph node (LN) dissection for patients with NSCLC ≤1 and >1 to 2 cm who underwent sublobar resection is still unclear. METHODS: A group of patients num...
Autores principales: | Zheng, Enkuo, Yang, Minglei, Li, Rui, Ni, Junjun, Xu, Xiang, Zhao, Guofang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
AME Publishing Company
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7330392/ https://www.ncbi.nlm.nih.gov/pubmed/32642107 http://dx.doi.org/10.21037/jtd-19-3773 |
Ejemplares similares
-
YRDC is upregulated in non-small cell lung cancer and promotes cell proliferation by decreasing cell apoptosis
por: Shen, Haibo, et al.
Publicado: (2020) -
Lobe-Specific Analysis of Sublobar Lung Resection for NSCLC Patients with Tumors ≤ 2 cm
por: Lei, Xi, et al.
Publicado: (2022) -
LncRNA RP11-805J14.5 functions as a ceRNA to regulate CCND2 by sponging miR-34b-3p and miR-139-5p in lung adenocarcinoma
por: Zhu, Huangkai, et al.
Publicado: (2022) -
Surgeons' preference sublobar resection for stage I NSCLC less than 3 cm
por: Huang, Chien‐Sheng, et al.
Publicado: (2020) -
Lobectomy with high-position single-intercostal two-port video-assisted thoracoscope for non-small cell lung cancer is a safe and effective surgical procedure
por: Zhao, Guofang, et al.
Publicado: (2020)